Orchestra BioMed Holdings, Inc. (OBIO) posted second-quarter financial results, with its net loss widening from the prior-year quarter, driven lower by higher interest expenses and the lack of partnership revenue.
Orchestra Q2 Loss Widens On Higher Expenditure; Gains $35 Mln In Strategic Capital
